High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma.

MLA

Coffey, David G., et al. “High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma.” JCO Precision Oncology, vol. 5, Apr. 2021, pp. 602–12. EBSCOhost, https://doi.org/10.1200/PO.20.00442.

APA

Coffey, D. G., Cowan, A. J., DeGraaff, B., Martins, T. J., Curley, N., Green, D. J., Libby, E. N., Silbermann, R., Chien, S., Dai, J., Morales, A., Gooley, T. A., Warren, E. H., & Becker, P. S. (2021). High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma. JCO Precision Oncology, 5, 602–612. https://doi.org/10.1200/PO.20.00442

Chicago

Coffey, David G., Andrew J. Cowan, Bret DeGraaff, Timothy J. Martins, Niall Curley, Damian J. Green, Edward N. Libby, et al. 2021. “High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma.” JCO Precision Oncology 5 (April): 602–12. doi:10.1200/PO.20.00442.